Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors

Glioblastoma (GBM) is the most aggressive malignant primary brain tumor in adults, with a median survival of 14.6 months. Recent efforts have focused on identifying clinically relevant subgroups to improve our understanding of pathogenetic mechanisms and patient stratification. Concurrently, the rol...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaffes, Ioannis, Szulzewsky, Frank, Chen, Zhihong, Herting, Cameron J., Gabanic, Ben, Velázquez Vega, José E., Shelton, Jennifer, Switchenko, Jeffrey M., Ross, James L., McSwain, Leon F., Huse, Jason T., Westermark, Bengt, Nelander, Sven, Forsberg-Nilsson, Karin, Uhrbom, Lene, Maturi, Naga Prathyusha, Cimino, Patrick. J., Holland, Eric C., Kettenmann, Helmut, Brennan, Cameron W., Brat, Daniel J., Hambardzumyan, Dolores
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791439/
https://www.ncbi.nlm.nih.gov/pubmed/31646100
http://dx.doi.org/10.1080/2162402X.2019.1655360

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791439/
https://www.ncbi.nlm.nih.gov/pubmed/31646100
http://dx.doi.org/10.1080/2162402X.2019.1655360

Ejemplares similares